Analytical Validation of BRAF Mutation Testing from Circulating Free DNA Using the Amplification Refractory Mutation Testing System
- 1 May 2014
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 16 (3) , 343-349
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- Cancer Research UK
This publication has 18 references indexed in Scilit:
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal CancerJournal of Clinical Oncology, 2010
- Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II studyBritish Journal of Cancer, 2009
- KRAS Mutation Testing in Colorectal CancerAdvances in Anatomic Pathology, 2009
- Toward Noninvasive Genomic Screening of Lung Cancer PatientsJournal of Clinical Oncology, 2009
- Cell-free DNA resuscitated for tumor testingNature Medicine, 2008
- Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patientsInternational Journal of Cancer, 2007
- Mutations of the BRAF gene in human cancerNature, 2002